Last reviewed · How we verify

NCT05765526

A Novel Electrolyzed Water Spray Treatment for the Discomfort or Itching of Patients With Scalp

Completed NA Last updated 25 April 2024
What this trial tests

NA trial testing A novel electrolyzed water spray in Scalp Dermatoses in 20 participants. Completed in 1 March 2024.

Timeline
29 January 2023
Primary endpoint
15 July 2023
1 March 2024

Quick facts

Lead sponsorDove Medical Press Ltd
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment20
Start date29 January 2023
Primary completion15 July 2023
Estimated completion1 March 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Dove Medical Press Ltd — full company profile →

Who can join

Adults 40 to 64, any sex, with Scalp Dermatoses. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to test whether the reduction of the discomfort or itching with the scalp of patients by use of the novel electrolyzed water spray will produce improvement in the condition of the scalp.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Dove Medical Press Ltd trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05765526.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing